Blinatumomab Beats Chemo, RAS Drugs vs Pancreatic Cancer, Creatine's Hidden Risk

Today's episode covers a practice-changing pediatric leukemia trial, a breakthrough RAS-targeted drug for pancreatic cancer, and new data linking creatine supplements to platelet-driven cancer spread. We also look at what continuous glucose monitoring reveals about heart risk, a state of the art review of heart attack care, and the global burden of secondhand smoke. A quick rundown covers shingles vaccine efficacy, ADHD in neurofibromatosis type one, diagnostic delays in lung fibrosis, and fasting's effect on the gut microbiome.